AQST Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

03

Preço $4.55

Capitalização de Mercado (MRQ) $571M

P/E (TTM) -7.0

EPS (TTM) $-0.65

Receita (TTM) $54M

ROE (TTM) 121.1%

Intervalo 52 Semanas $3–$8

AQST Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

04

intervalo

barras

A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

06

Receita$45M

2017-12-31 → 2025-12-31

EPS$-0.78

2020-12-31 → 2025-12-31

Fluxo de caixa livre$-53M

2018-12-31 → 2025-12-31

Margem líquida-144.6%

2018-12-31 → 2025-12-31

Avaliação e Proporções 07–12

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica	AQST	média 5A	Mediana de Pares	Veredito
P/E (TTM)	-7.0média 5A ≈-6.7	≈-6.7	·	·
P/S (TTM)	10.6média 5A ≈6.1	≈6.1	4.9	Sobreavaliado
P/B (MRQ)	-10.1média 5A ≈-6.5	≈-6.5	·	·
Preço / FCF (TTM)	-12.4média 5A ≈-10.4	≈-10.4	·	·
Preço / Fluxo de Caixa (TTM)	-12.6média 5A ≈-11.2	≈-11.2	·	·

A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica	AQST	média 5A	Mediana de Pares	Veredito
Margem Operacional (TTM)	-97.5%média 5A ≈-79.9%	≈-79.9%	-1.8%	Fraco
EBITDA Margin (Margem EBITDA)	-159.5%média 5A ≈-79.9%	≈-79.9%	1.8%	Fraco
Margem de Impostos Pré-Tributação (TTM)	-144.6%média 5A ≈-106.5%	≈-106.5%	12.8%	Fraco
Margem de Lucro Líquido (TTM)	-144.6%média 5A ≈-106.6%	≈-106.6%	-7.5%	Fraco
ROA (TTM)	-69.3%média 5A ≈-67.5%	≈-67.5%	-14.9%	Fraco
ROE (TTM)	121.1%média 5A ≈79.2%	≈79.2%	37.8%	Primeira linha
ROIC	211.1%média 5A ≈70.9%	≈70.9%	7.1%	Primeira linha

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica	Tendência de 5 anos	AQST	média 5A	Mediana de Pares	Veredito
Índice de liquidez corrente (MRQ)		7.2média 5A ≈2.6	≈2.6	4.3	Liquidez forte
Quick Ratio (Índice de Liquidez Seca)		0.4	·	2.6	Liquidez forte

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica	AQST	média 5A	Mediana de Pares	Veredito
Revenue YoY (Receita Ano a Ano)	-22.6%média 5A ≈0.39%	≈0.39%	·	·
Revenue CAGR 3Y (CAGR Receita 3A)	-2.2%média 5A ≈1.8%	≈1.8%	·	·
Revenue CAGR 5Y (CAGR Receita 5A)	-0.58%	·	·	·

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica	AQST	média 5A	Mediana de Pares	Veredito
EPS (Diluted) (EPS (Diluído))	$-0.78média 5A ≈$-0.88	≈$-0.88	·	·
Revenue / Share (Receita / Ação)	$0.42média 5A ≈$0.84	≈$0.84	·	·
Cash Flow / Share (Fluxo de Caixa / Ação)	$-0.49média 5A ≈$-0.41	≈$-0.41	·	·

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica	AQST	média 5A	Mediana de Pares	Veredito
Asset Turnover (Giro do Ativo)	0.3média 5A ≈0.7	≈0.7	0.4	Em linha
Inventory Turnover (Giro de Estoque)	3.0média 5A ≈3.0	≈3.0	1.2	Primeira linha
Receivables Turnover (Giro de Contas a Receber)	3.5	·	3.5	Fraco
Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.)	≈$303.0K	·	·	·

valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

14

Surpresa Média 6.6%

Próximo relatório Nov 03, 2026

Período	Relatório	EPS Actual	EPS est.	Surpresa
30 de Junho de 2026	Ago 11, 2026	$-0.08	$-0.11	24.1%
31 de Março de 2026	Mai 13, 2026	$-0.07	$-0.14	50.0%
31 de Dezembro de 2025		$-0.15	$-0.14	-10.9%
30 de Setembro de 2025		$-0.14	$-0.14	-3.6%
30 de Junho de 2025		$-0.14	$-0.17	18.5%
31 de Março de 2025		$-0.24	$-0.17	-38.4%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

15

Demonstração de Resultados 16

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$45M	$58M	$51M	$48M	$51M	$46M	$53M	$67M	$67M
Cost of Revenue	$19M	$18M	$21M	$19M	·	$13M	$20M	·	·
R&D Expense	$17M	$20M	$13M	$17M	$17M	$20M	$21M	$23M	$22M
SG&A Expense	$80M	$50M	$32M	$53M	$53M	$56M	$64M	$72M	$25M
Operating Expenses	$116M	$88M	$66M	$90M	$86M	$89M	$105M	$116M	$67M
Operating Income	$-71M	$-31M	$-15M	$-42M	$-35M	$-43M	$-53M	$-49M	$-113.0K
Interest Expense	·	·	$6M	$7M	$10M	$11M	$9M	$8M	$8M
Interest Income	·	·	·	·	·	$132.0K	$636.0K	·	·
Pretax Income	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	$-9M
Income Tax	$0	$-14.0K	$245.0K	$0	$0	$0	$0	$0	$0
Net Income	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	$-9M
EPS (Basic)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·
EPS (Diluted)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·
Shares (Basic)	106,926,528	86,726,211	61,255,864	48,734,377	38,077,660	33,651,127	·	·	·
Shares (Diluted)	106,926,528	86,726,211	61,255,864	48,734,377	38,077,660	33,651,127	·	·	·
EBITDA	$-71M	$-31M	$-15M	$-42M	$-35M	$-43M	$-53M	$-46M	·

Balanço Patrimonial 24

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$121M	$72M	$24M	$27M	$28M	$32M	$49M	$61M	$17M
Receivables	$18M	$7M	$8M	·	·	·	·	·	$6M
Inventory	$6M	$6M	$7M	$6M	$4M	$2M	$3M	$5M	$4M
Prepaid Expense	$4M	$3M	$2M	$2M	$3M	$3M	$3M	$2M	$591.0K
Current Assets	$149M	$88M	$41M	$40M	$47M	$45M	$68M	$74M	$28M
PP&E (Net)	$4M	$4M	$4M	$4M	$5M	$7M	$10M	$12M	$13M
PP&E (Gross)	$48M	$47M	$47M	$46M	$45M	$48M	$48M	$47M	$45M
Accum. Depreciation	$44M	$44M	$43M	$42M	$40M	$41M	$38M	$35M	$32M
Intangibles	$0	$0	$1M	$1M	$51.0K	$102.0K	$153.0K	$204.0K	$254.0K
Other Non-current Assets	$3M	$4M	$5M	$6M	$7M	$8M	$286.0K	$239.0K	$1M
Total Assets	$160M	$101M	$57M	$57M	$62M	$63M	$78M	$87M	$43M
Accounts Payable	$30M	$10M	$9M	$10M	$8M	$7M	$12M	$20M	$10M
Accrued Liabilities	$5M	$6M	$6M	$8M	$9M	$9M	$5M	$7M	$4M
Current Liabilities	$48M	$19M	$18M	$40M	$22M	$21M	$19M	$33M	$15M
Capital Leases	$4M	$5M	$5M	$5M	$2M	$3M	$0	·	·
Other Non-current Liabilities	$7M	$2M	$2M	$2M	$2M	$2M	$1M	·	·
Total Liabilities	$194M	$162M	$164M	$176M	$144M	$111M	$85M	$77M	$70M
Long-term Debt	$45M	$45M	$45M	·	·	$52M	$70M	·	·
Common Stock	$122.0K	$91.0K	$69.0K	$55.0K	$41.0K	$35.0K	$34.0K	$25.0K	$0
Paid-in Capital	$413M	$303M	$213M	$193M	$175M	$138M	$124M	$71M	$0
Retained Earnings	$-447M	$-363M	$-319M	$-311M	$-257M	$-186M	$-130M	$-61M	$-120M
Stockholders' Equity	$-34M	$-60M	$-106M	$-119M	$-82M	$-48M	$-6M	$10M	$-26M
Liabilities + Equity	$160M	$101M	$57M	$57M	$62M	$63M	$78M	$87M	$43M
Shares Outstanding	122,044,299	91,413,742	68,533,085	54,827,734	41,228,736	34,569,254	33,562,885	24,957,309	·

Fluxo de Caixa 13

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$548.0K	$718.0K	$1M	$2M	$3M	$3M	$3M	$3M	$4M
Stock-based Comp	$8M	$7M	$3M	$4M	$7M	$7M	$7M	$30M	$0
Deferred Tax	$0	$0	$0	$0	·	·	·	·	·
Amort. of Intangibles	$0	$78.0K	$157.0K	$116.0K	$51.0K	$51.0K	$50.0K	$50.0K	$51.0K
Other Non-cash	·	·	·	·	·	·	·	$15M	·
Operating Cash Flow	$-52M	$-36M	$-6M	$-10M	$-33M	$-45M	$-60M	$-13M	$6M
CapEx	$562.0K	$159.0K	$995.0K	$1M	$913.0K	$517.0K	$663.0K	$2M	$2M
Investing Cash Flow	$-562.0K	$-159.0K	$-995.0K	$-3M	$-913.0K	$-517.0K	$-663.0K	$-2M	$-2M
Financing Cash Flow	$103M	$84M	$4M	$12M	$30M	$28M	$50M	$58M	$4M
Net Change in Cash	$50M	$48M	$-3M	$-751.0K	$-4M	$-18M	·	$43M	$8M
Taxes Paid	$0	$305.0K	$0	·	·	·	·	·	·
Free Cash Flow	$-53M	$-36M	$-7M	$-11M	$-34M	$-46M	$-61M	$-15M	·
Levered FCF	·	·	$-14M	$-17M	$-44M	$-57M	$-70M	$-23M	·

Lucratividade 7

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%	-93.5%	-100.1%	-72.6%	·
Net Margin	-188.1%	-76.7%	-15.6%	-114.1%	-138.8%	-121.7%	-125.9%	-91.0%	·
Pretax Margin	-188.1%	-76.7%	-15.1%	-114.1%	-138.8%	-121.7%	-125.9%	-91.0%	·
EBITDA Margin	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%	-93.5%	-100.1%	-67.8%	·
ROA	-64.0%	-55.6%	-13.8%	-91.4%	-113.0%	-78.9%	-80.1%	-94.5%	·
ROE	157.7%	83.6%	7.5%	48.1%	99.0%	131.2%	326.5%	-366.2%	·
ROIC	211.1%	51.1%	14.6%	35.5%	42.2%	88.4%	860.3%	-485.5%	·

Liquidez e Solvência 3

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	3.1	4.7	2.2	1.0	2.2	2.1	3.7	2.3	·
Quick Ratio	0.4	0.4	·	·	·	1.5	2.7	1.8	·
Interest Coverage	·	·	-2.4	-6.4	-3.5	-3.9	-5.7	-6.3	·

Eficiência 3

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.3	0.7	0.9	0.8	0.8	0.6	0.6	1.0	·
Inventory Turnover	3.0	2.8	3.3	·	·	4.9	·	·	·
Receivables Turnover	3.5	7.3	·	·	·	·	·	·	·

Por Ação 5

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$-0.28	$-0.66	$-1.55	$-2.16	$-1.99	$-1.40	$-0.18	$0.40	·
Revenue / Share	$0.42	$0.66	$0.83	$0.98	$1.33	·	·	·	·
Cash Flow / Share	$-0.49	$-0.41	$-0.10	$-0.20	$-0.87	·	·	·	·
Cash / Share	·	·	·	·	·	$0.92	$1.47	$2.43	·
EPS (TTM)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·

Taxas de Crescimento 3

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-22.6%	13.8%	6.1%	-6.2%	10.9%	·	·	·	·
Revenue CAGR 3Y	-2.2%	4.2%	3.3%	·	·	·	·	·	·
Revenue CAGR 5Y	-0.58%	·	·	·	·	·	·	·	·

Avaliação (TTM) 9

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$45M	$58M	$51M	$48M	$51M	$46M	$53M	$67M	·
Net Income TTM	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	·
Market Cap	$788M	$325M	$138M	$49M	$160M	$185M	$195M	$157M	·
P/E	-8.3	-7.0	-15.5	-0.8	-2.1	-3.2	·	·	·
P/S	17.7	5.7	2.7	1.0	3.2	4.0	3.7	2.3	·
P/B	-23.4	-5.4	-1.3	-0.4	-2.0	-3.8	-31.9	15.6	·
P / Cash Flow	-15.0	-9.1	-21.7	-5.1	-4.9	-4.1	-3.2	-12.1	·
P / FCF	-14.9	-9.1	-18.8	-4.6	-4.7	-4.0	-3.2	-10.6	·
Earnings Yield	-12.1%	-14.3%	-6.4%	-124.2%	-47.6%	-31.0%	·	·	·

Demonstração de Resultados 15

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$14M	$14M	$13M	$13M	$10M	$9M	$12M	$14M	$20M	$12M	$13M	$13M	$13M	$11M	$11M	$11M
Cost of Revenue	$4M	$3M	$6M	$5M	$5M	$4M	$5M	$4M	$5M	$4M	$5M	$5M	$7M	$5M	$5M	$5M
R&D Expense	$4M	$4M	$3M	$5M	$4M	$5M	$5M	$5M	$4M	$6M	$3M	$3M	$3M	$4M	$4M	$3M
SG&A Expense	$14M	$11M	$33M	$15M	$13M	$19M	$16M	$12M	$11M	$11M	$10M	$7M	$7M	$7M	$12M	$12M
Operating Expenses	$22M	$19M	$42M	$24M	$21M	$28M	$25M	$22M	$20M	$21M	$17M	$15M	$17M	$16M	$21M	$20M
Operating Income	$-8M	$-4M	$-29M	$-11M	$-11M	$-19M	$-14M	$-8M	$55.0K	$-9M	$-4M	$-2M	$-4M	$-5M	$-11M	$-9M
Interest Expense	·	·	·	·	·	·	·	·	$3M	$3M	·	$1M	$1M	$1M	$2M	$2M
Pretax Income	$-23M	$-8M	$-32M	$-15M	$-14M	$-23M	$-17M	$-12M	$-3M	$-13M	$-8M	$-2M	$-6M	$8M	$-12M	$-13M
Income Tax	$0	$0	$0	$0	$0	$0	$-14.0K	$0	$0	$0	$101.0K	$-140.0K	$284.0K	$0	$0	$0
Net Income	$-23M	$-8M	$-32M	$-15M	$-14M	$-23M	$-17M	$-12M	$-3M	$-13M	$-8M	$-2M	$-6M	$8M	$-12M	$-13M
EPS (Basic)	$-0.18	$-0.07	$-0.26	$-0.14	$-0.14	$-0.24	$-0.18	$-0.13	$-0.03	$-0.17	$-0.15	$-0.03	$-0.10	$0.15	$-0.21	$-0.23
EPS (Diluted)	$-0.18	$-0.07	$-0.26	$-0.14	$-0.14	$-0.24	$-0.18	$-0.13	$-0.03	$-0.17	$-0.11	$-0.03	$-0.10	$0.11	$-0.21	$-0.23
Shares (Basic)	124,994,165	122,609,995	·	110,584,371	99,326,701	95,497,056	·	91,082,081	90,911,626	73,614,710	·	64,678,761	57,350,902	55,631,947	·	53,424,922
Shares (Diluted)	124,994,165	122,609,995	·	110,584,371	99,326,701	95,497,056	·	91,082,081	90,911,626	73,614,710	·	64,678,761	57,350,902	73,792,886	·	53,424,922
EBITDA	$-8M	$-4M	·	$-11M	$-11M	$-19M	·	$-8M	$55.0K	$-9M	·	$-2M	$-4M	$-5M	·	$-9M

Balanço Patrimonial 24

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$98M	$111M	·	$129M	$61M	$69M	·	$78M	$90M	$95M	·	$25M	$22M	$27M	·	$19M
Receivables	$9M	$7M	$18M	·	·	·	$7M	·	·	·	$8M	·	·	·	·	·
Inventory	$7M	$8M	$6M	$8M	$8M	$7M	$6M	$7M	$7M	$8M	$7M	$7M	$6M	$7M	$6M	$7M
Prepaid Expense	$3M	$5M	$4M	$3M	$1M	$3M	$3M	$2M	$1M	$2M	$2M	$2M	$1M	$2M	$2M	$2M
Current Assets	$118M	$130M	$149M	$152M	$82M	$89M	$88M	$97M	$104M	$113M	$41M	$42M	$40M	$44M	$40M	$38M
PP&E (Net)	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$4M	$4M	$4M
PP&E (Gross)	$48M	$48M	$48M	$48M	$48M	$47M	$47M	$47M	$47M	$47M	$47M	$47M	$47M	$46M	$46M	$46M
Accum. Depreciation	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$43M	$43M	$43M	$43M	$43M	$42M	$42M	$42M	$42M
Intangibles	·	·	$0	$0	$0	$0	$0	$0	$0	$1M	$1M	$1M	$1M	$1M	$1M	$1M
Other Non-current Assets	$2M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$6M	$6M	$6M
Total Assets	$132M	$141M	$160M	$164M	$94M	$102M	$101M	$110M	$118M	$130M	$57M	$59M	$57M	$61M	$57M	$52M
Accounts Payable	$9M	$12M	$30M	$11M	$12M	$12M	$10M	$8M	$6M	$11M	$9M	$10M	$11M	$12M	$10M	$11M
Accrued Liabilities	$5M	$3M	$5M	$5M	$5M	$3M	$6M	$5M	$6M	$5M	$6M	$5M	$4M	$5M	$8M	$8M
Current Liabilities	$16M	$32M	$48M	$26M	$23M	$18M	$19M	$15M	$14M	$18M	$18M	$24M	$39M	$40M	$40M	$37M
Capital Leases	$8M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$6M	$6M	$6M	$5M	$1M
Other Non-current Liabilities	$6M	$6M	$7M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Total Liabilities	$189M	$175M	$194M	$168M	$166M	$163M	$162M	$155M	$153M	$166M	$164M	$162M	$164M	$171M	$176M	$160M
Long-term Debt	$55M	$45M	$45M	$45M	$45M	$45M	·	$45M	$45M	$45M	·	$39M	$39M	$42M	·	$52M
Common Stock	$126.0K	$124.0K	$122.0K	$121.0K	$99.0K	$99.0K	$91.0K	$91.0K	$91.0K	$90.0K	$69.0K	$67.0K	$62.0K	$56.0K	$55.0K	$54.0K
Paid-in Capital	$421M	$421M	$413M	$411M	$327M	$325M	$303M	$301M	$299M	$296M	$213M	$208M	$202M	$194M	$193M	$191M
Retained Earnings	$-478M	$-455M	$-447M	$-415M	$-400M	$-386M	$-363M	$-346M	$-335M	$-332M	$-319M	$-311M	$-309M	$-303M	$-311M	$-299M
Stockholders' Equity	$-57M	$-34M	$-34M	$-4M	$-73M	$-61M	$-60M	$-45M	$-35M	$-36M	$-106M	$-103M	$-107M	$-109M	$-119M	$-108M
Liabilities + Equity	$132M	$141M	$160M	$164M	$94M	$102M	$101M	$110M	$118M	$130M	$57M	$59M	$57M	$61M	$57M	$52M
Shares Outstanding	125,511,648	124,284,542	122,044,299	121,658,113	99,353,270	99,317,153	91,413,742	91,178,193	91,059,760	90,478,731	68,533,085	66,740,765	61,615,959	55,922,361	54,827,734	53,852,126

Fluxo de Caixa 11

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$136.0K	$113.0K	$130.0K	$139.0K	$140.0K	$139.0K	$147.0K	$159.0K	$205.0K	$207.0K	$467.0K	$264.0K	$289.0K	$325.0K	$397.0K	$596.0K
Stock-based Comp	$3M	$2M	$1M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$940.0K	$774.0K	$631.0K	$344.0K	$714.0K	$535.0K
Amort. of Intangibles	·	·	$0	$0	$0	$0	$0	$0	$39.0K	$39.0K	$40.0K	$39.0K	$39.0K	$39.0K	$51.0K	$39.0K
Operating Cash Flow	$-9M	$-15M	$-8M	$-13M	$-8M	$-23M	$-6M	$-12M	$-7M	$-10M	$-5M	$-2M	$-8M	$9M	$8M	$3M
CapEx	$212.0K	$52.0K	$85.0K	$235.0K	$107.0K	$135.0K	$15.0K	$80.0K	$35.0K	$29.0K	$16.0K	$151.0K	$826.0K	$2.0K	$26.0K	$217.0K
Investing Cash Flow	$-212.0K	$-52.0K	$-85.0K	$-235.0K	$-107.0K	$-135.0K	$-15.0K	$-80.0K	$-35.0K	$-29.0K	$-16.0K	$-151.0K	$-826.0K	$-2.0K	$-26.0K	$-2M
Financing Cash Flow	$-3M	$4M	$660.0K	$81M	$-100.0K	$21M	$157.0K	$-17.0K	$2M	$82M	$4M	$5M	$4M	$-9M	$234.0K	$-138.0K
Net Change in Cash	$-12M	$-10M	$-8M	$69M	$-8M	$-3M	$-6M	$-12M	$-5M	$71M	$-1M	$2M	$-4M	$-391.0K	$9M	$954.0K
Taxes Paid	·	·	$0	$0	$-2M	$2M	$0	$0	$-698.0K	$1M	$0	$0	·	·	·	·
Free Cash Flow	·	$-15M	·	·	·	$-24M	·	·	·	$-10M	·	·	·	$9M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-13M	·	·	·	$7M	·	·

Lucratividade 7

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-59.5%	-29.1%	·	-89.6%	-113.7%	-222.1%	·	-61.2%	0.27%	-74.3%	·	-18.3%	-31.8%	-41.4%	·	-77.2%
Net Margin	-165.5%	-55.8%	·	-120.6%	-135.4%	-263.0%	·	-85.0%	-13.7%	-106.4%	·	-15.7%	-43.7%	72.5%	·	-109.4%
Pretax Margin	-165.5%	-55.8%	·	-120.6%	-135.4%	-263.0%	·	-85.0%	-13.7%	-106.4%	·	-16.7%	-41.6%	72.5%	·	-109.4%
EBITDA Margin	-59.5%	-29.1%	·	-89.6%	-113.7%	-222.1%	·	-61.2%	0.27%	-74.3%	·	-18.3%	-31.8%	-41.4%	·	-77.2%
ROA	-20.2%	-6.6%	·	-11.3%	-12.8%	-19.8%	·	-13.6%	-3.1%	-13.5%	·	-3.7%	-10.2%	13.7%	·	-21.4%
ROE	35.4%	17.0%	·	62.4%	25.1%	47.2%	·	15.5%	3.9%	17.6%	·	1.9%	5.7%	-8.0%	·	14.9%
ROIC	14.5%	12.3%	·	279.4%	15.7%	31.8%	·	18.2%	-0.16%	24.7%	·	2.2%	4.2%	4.2%	·	8.2%

Liquidez e Solvência 3

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	7.2	4.1	·	5.9	3.5	4.9	·	6.4	7.5	6.3	·	1.8	1.0	1.1	·	1.0
Quick Ratio	6.5	3.7	·	5.0	2.6	3.8	·	5.1	6.5	5.3	·	1.0	0.6	0.7	·	0.5
Interest Coverage	·	·	·	·	·	·	·	·	0.0	-3.2	·	-1.9	-3.1	-3.2	·	-5.4

Eficiência 3

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.2	0.2	0.1	·	0.2	0.2	0.2	·	0.2
Inventory Turnover	0.5	0.5	·	0.6	0.6	0.5	·	0.6	0.7	0.6	·	0.7	1.2	0.8	·	1.0
Receivables Turnover	1.7	4.2	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Por Ação 5

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-0.45	$-0.27	·	$-0.03	$-0.73	$-0.61	·	$-0.50	$-0.39	$-0.40	·	$-1.54	$-1.73	$-1.95	·	$-2.00
Revenue / Share	$0.11	$0.12	·	$0.12	$0.10	$0.09	·	$0.15	$0.22	$0.16	·	$0.20	$0.23	$0.15	·	$0.21
Cash Flow / Share	·	$-0.12	·	·	·	$-0.24	·	·	·	$-0.14	·	·	·	$0.12	·	·
Cash / Share	$0.78	$0.89	·	$1.06	$0.61	$0.69	·	$0.85	$0.99	$1.05	·	$0.37	$0.36	$0.48	·	$0.35
EPS (TTM)	$-0.65	$-0.61	·	$-0.70	$-0.69	$-0.58	·	$-0.44	$-0.34	$-0.41	·	$-0.23	$-0.43	$-0.69	·	$-1.65

Avaliação (TTM) 8

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$54M	$50M	·	$43M	$44M	$54M	·	$59M	$58M	$52M	·	$48M	$47M	$47M	·	$48M
Net Income TTM	$-78M	$-69M	·	$-69M	$-65M	$-54M	·	$-35M	$-26M	$-29M	·	$-12M	$-23M	$-33M	·	$-71M
Market Cap	$522M	$516M	·	$680M	$329M	$288M	·	$454M	$237M	$385M	·	$102M	$102M	$64M	·	$63M
P/E	-6.4	-6.8	·	-8.0	-4.8	-5.0	·	-11.3	-7.6	-10.4	·	-6.7	-3.8	-1.7	·	-0.7
P/S	9.7	10.3	·	15.7	7.5	5.3	·	7.7	4.1	7.5	·	2.1	2.2	1.4	·	1.3
P/B	-9.2	-15.1	·	-165.5	-4.5	-4.7	·	-10.0	-6.7	-10.6	·	-1.0	-1.0	-0.6	·	-0.6
P / Cash Flow	·	-34.8	·	·	·	-12.3	·	·	·	-37.1	·	·	·	7.2	·	·
Earnings Yield	-15.6%	-14.7%	·	-12.5%	-20.8%	-20.0%	·	-8.8%	-13.1%	-9.6%	·	-15.0%	-26.1%	-60.5%	·	-141.0%

Período mais recente à esquerda · valores nulos mostrados como ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

16

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Receita	$45M	$58M	$51M	$48M	$51M
Margem Operacional %	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%
Lucro líquido	$-84M	$-44M	$-8M	$-54M	$-71M
EPS Diluído	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Índice de liquidez corrente	3.1	4.7	2.2	1.0	2.2
Índice de Liquidez Seca	0.4	0.4	·	·	·

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Fluxo de caixa livre	$-53M	$-36M	$-7M	$-11M	$-34M

Investidores institucionais (13F) 196 declarantes · $337.8M total · Em 30 de Junho de 2026

17

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Detentores 196

Valor detido $337.8M

Novas posições 26

Posições encerradas 18

Atividade institucional — Q2 2026 vs trimestre anterior

Novas posições	Posições encerradas	Aumentou	Diminuído	Variação líquida de ações
26 (-23 vs trimestre anterior)	18 (-29 vs trimestre anterior)	68 (+9 vs trimestre anterior)	49 (0 vs trimestre anterior)	-1.2M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição	Valor	Ações	% de 13F rastreado	Tipo
Bratton Capital Management, L.P.	$40.813.585	9.810.958	12,08%	Ações
VANGUARD GROUP INC	$38.064.478	5.892.334	11,27%	Ações
BlackRock, Inc.	$33.568.590	8.069.373	9,94%	Ações
RTW INVESTMENTS, LP	$30.894.119	7.426.471	9,15%	Ações
VANGUARD CAPITAL MANAGEMENT LLC	$19.071.657	4.584.533	5,65%	Ações
FEDERATED HERMES, INC.	$12.948.253	3.112.561	3,83%	Ações
STATE STREET CORP	$12.180.563	2.928.020	3,61%	Ações
GEODE CAPITAL MANAGEMENT, LLC	$10.913.743	2.622.888	3,23%	Ações
SAMSARA BIOCAPITAL, LLC	$10.400.000	2.500.000	3,08%	Ações
BANK OF AMERICA CORP /DE/	$6.940.640	1.668.423	2,05%	Ações
Sio Capital Management, LLC	$6.182.488	1.486.175	1,83%	Ações
Propel Bio Management, LLC	$6.000.372	1.442.397	1,78%	Ações
TWO SIGMA INVESTMENTS, LP	$5.329.904	1.281.227	1,58%	Ações
Nuveen, LLC	$5.055.336	1.215.225	1,50%	Ações
WELLS FARGO & COMPANY/MN	$4.530.394	1.089.037	1,34%	Ações
COMMONWEALTH EQUITY SERVICES, LLC	$4.352.090	1.046.175	1,29%	Ações
BARCLAYS PLC	$4.146.126	996.665	1,23%	Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.951.168	949.800	1,17%	Opção de compra
Blue Owl Capital Holdings LP	$3.922.597	942.932	1,16%	Ações
WASATCH ADVISORS LP	$3.645.011	878.316	1,08%	Ações
NORTHERN TRUST CORP	$3.457.589	831.151	1,02%	Ações
BNP PARIBAS FINANCIAL MARKETS	$3.305.902	794.688	0,98%	Ações
Balyasny Asset Management L.P.	$3.097.270	744.536	0,92%	Ações
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.054.459	734.245	0,90%	Ações
MORGAN STANLEY	$2.739.848	658.617	0,81%	Ações
VANGUARD FIDUCIARY TRUST CO	$2.709.038	651.211	0,80%	Ações
DAFNA Capital Management LLC	$2.687.006	645.915	0,80%	Ações
Everstar Asset Management, LLC	$2.545.683	611.943	0,75%	Ações
TWO SIGMA ADVISERS, LP	$2.147.304	332.400	0,64%	Ações
AWM Investment Company, Inc.	$1.977.664	475.400	0,59%	Ações
GOLDMAN SACHS GROUP INC	$1.949.247	468.569	0,58%	Ações
Bracebridge Capital, LLC	$1.910.339	459.216	0,57%	Ações
UBS Group AG	$1.907.002	458.414	0,56%	Ações
CITADEL ADVISORS LLC	$1.881.140	452.197	0,56%	Ações
JANE STREET GROUP, LLC	$1.819.958	437.490	0,54%	Ações
RENAISSANCE TECHNOLOGIES LLC	$1.731.592	416.248	0,51%	Ações
STIFEL FINANCIAL CORP	$1.505.516	361.903	0,45%	Ações
Man Group plc	$1.463.072	351.700	0,43%	Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.286.272	309.200	0,38%	Opção de venda
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.274.599	306.394	0,38%	Ações
WELLINGTON MANAGEMENT GROUP LLP	$1.254.852	301.647	0,37%	Ações
MARSHALL WACE, LLP	$1.188.340	285.659	0,35%	Ações
Walleye Capital LLC	$1.175.483	282.568	0,35%	Ações
Simplify Asset Management Inc.	$1.159.488	278.723	0,34%	Ações
Bank of New York Mellon Corp	$1.146.264	275.544	0,34%	Ações
Russell Investments Group, Ltd.	$1.083.599	260.481	0,32%	Ações
Rosalind Advisors, Inc.	$1.040.000	250.000	0,31%	Ações
Latash Investments, LLC	$1.011.437	243.134	0,30%	Ações
Hudson Bay Capital Management LP	$973.440	234.000	0,29%	Ações
Lido Advisors, LLC	$895.715	215.316	0,27%	Ações

Mostrar todos os 196 proprietários institucionais →

Executivos da empresa 29 insiders · 19 diretores · 11 conselheiros

19

Investidor com informação privilegiada	Função	Última atividade	Ações detidas	Vendas 12m	Líquido 12m
Daniel Barber	President and CEO	15 de Setembro de 2026 S	652.317	7	$-1.220.735
Keith J Kendall	CEO and President	10 de Março de 2022 A	1.000	0	$0
Ernest A Toth JR	Chief Financial Officer	5 de Maio de 2026 F	283.460	1	$-242.919
John T. Maxwell	SVP-Chief Financial Officer	18 de Agosto de 2020 S	150.614	0	$0
Cassie Jung	Chief Operating Officer	3 de Setembro de 2026 X	206.833	2	$-664.649
Sherry Korczynski	Chief Commercial Officer	9 de Setembro de 2026 M	235.689	2	$-111.315
Peter E. Boyd	Chief People Officer	9 de Setembro de 2026 X	284.024	2	$-194.324
Thomas A. Zalewski	Chief Legal Officer	18 de Maio de 2026 A	100.000	0	$0
Melina Cioffi	SVP, Regulatory Affairs	15 de Maio de 2026 F	273.200	1	$-105.547
Lori J Braender	Corporate Secretary	7 de Maio de 2026 F	231.042	1	$-167.225
Matthew J. Greenhawt	Chief Medical Officer	9 de Março de 2026 A	75.000	0	$0
Matthew W. Davis	Chief Development Officer	9 de Março de 2026 A	100.000	0	$0
Carl N Kraus	Chief Medical Officer	15 de Outubro de 2025 S	282.475	1	$-141.904
Stephen Wargacki	Chief Science Officer	7 de Março de 2025 A	343.552	0	$0
Alexander Mark Schobel	Chief Innovation/Tech Officer	9 de Março de 2024 F	980.726	0	$0
Ken W. Marshall	SVP, Chief Commercial Officer	9 de Agosto de 2023 A	150.000	0	$0
Kenneth Truitt	Chief Medical Officer	6 de Setembro de 2022 A	·	0	$0
Theresa Wood	SVP-HR and Org. Development	10 de Março de 2022 A	80.765	0	$0
Gary H Slatko	SVP, Chief Medical Officer	16 de Março de 2020 A	·	0	$0
Julie Krop	Conselheiro	23 de Junho de 2026 M	0	1	$-125.500
Abigail L. Jenkins	Conselheiro	10 de Junho de 2026 A	·	0	$0
Marco Taglietti	Conselheiro	10 de Junho de 2026 A	·	0	$0
John Cochran	Conselheiro	10 de Junho de 2026 A	99.486	0	$0
Gregory B Brown	Conselheiro	10 de Junho de 2026 A	·	0	$0
Timothy E Morris	Conselheiro	10 de Junho de 2026 A	·	0	$0
COSTA SANTO J	Conselheiro	20 de Junho de 2024 A	·	0	$0
Nancy Lurker	Conselheiro	15 de Junho de 2021 A	·	0	$0
James S Scibetta	Conselheiro	15 de Junho de 2021 A	31.635	0	$0
Douglas K Bratton	Detentor de 10%	2 de Dezembro de 2024 G	199.841	0	$0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 16 ETFs

20

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo	Peso	Unidades	Em	Fonte
PILL · Direxion Shares ETF Trust	0,51%	28.299 NS	31 de Julho de 2026	N-PORT
QQQS · Invesco Exchange-Traded Fund Trust …	0,47%	23.471 SH	1 de Outubro de 2026	Diário
IWC · iShares Trust	0,13%	367.240 SH	11 de Setembro de 2026	Diário
IBBQ · Invesco Exchange-Traded Fund Trust …	0,04%	8.980 SH	1 de Outubro de 2026	Diário
VTWV · VANGUARD SCOTTSDALE FUNDS	0,02%	59.348 SH	19 de Agosto de 2026	Diário
IWM · iShares Trust	0,02%	2.767.037 SH	11 de Setembro de 2026	Diário
IWO · iShares Trust	0,01%	374.338 SH	11 de Setembro de 2026	Diário
RSSL · Global X Funds	0,01%	51.582 NS	31 de Julho de 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	621.390 SH	19 de Agosto de 2026	Diário
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	43.284 SH	19 de Agosto de 2026	Diário
ITOT · iShares Trust	0,00%	165.523 SH	11 de Setembro de 2026	Diário
IWV · iShares Trust	0,00%	34.314 SH	11 de Setembro de 2026	Diário
VXF · VANGUARD INDEX FUNDS	0,00%	1.077.349 SH	19 de Agosto de 2026	Diário
VTI · VANGUARD INDEX FUNDS	0,00%	3.403.709 SH	19 de Agosto de 2026	Diário
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	10.223 SH	19 de Agosto de 2026	Diário
IWN · iShares Trust	·	638.760 SH	11 de Setembro de 2026	Diário

AQST Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

21

classificação · 15 analistas COMPRA

Alvo mediano $10.00 +119,8%

4 26,7% Compra forte

10 66,7% Compra

1 6,7% Manter

0 0,0% Venda

0 0,0% Venda forte

Preço-alvo de 12 meses

9 analistas · 2026-09-27

Alvo médio $9.33 +105,1%

← Abaixo de todos os alvos Preço atual $4.55

Mín$6.00 Média$9.33 Máx$11.00

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

22

Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.

Ticker	Capitalização de Mercado	P/E	Receita YoY	Margem Líquida	ROE	Margem Bruta
AQST	$788M	-8.3	-22.6%	-188.1%	157.7%	·
COLL	$1.47B	26.8	23.6%	8.1%	23.5%	59.4%
ACRS	$363M	-5.7	-58.2%	-829.6%	-55.3%	·
CRMD	$922M	5.7	617.0%	52.3%	52.1%	88.5%
ZVRA	$509M	6.6	350.9%	78.2%	61.2%	·
PHAT	$1.18B	-5.5	216.9%	-126.4%	52.4%	87.1%
EOLS	$432M	-8.3	11.6%	-17.4%	247.3%	66.3%
CTNM	·	-5.3	·	·	-27.7%	·
ARVN	$753M	-10.4	-0.30%	-30.8%	-15.5%	·

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

26

Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

AQST Aquestive Therapeutics, Inc. - Common Stock